OTC Markets OTCQB - Delayed Quote USD

Biotricity, Inc. (BTCY)

0.4600

+0.0100

+(2.22%)

At close: April 25 at 3:56:11 PM EDT

Biotricity Recognized by Financial Times as One of 2025’s Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed

REDWOOD CITY, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY) a leading Technology-as-a-Service (Taas) company specializing in cutting-edge diagnostic and chronic disease management solutions for healthcare providers and consumers, is proud to announce its inclusion on the Financial Times’ list of The Americas’ Fastest-Growing Companies 2025. This recognition highlights Biotricity’s innovation in digital health and exceptional growth of 256.4% during a period marked by u

GlobeNewswire 19 days ago

BTCY
+2.22%
Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease Management

Biotricity’s latest patents focus on a multi-biometric device platform that functions as both a patch and watch, advancing biometric monitoring solutions for remote patient care. REDWOOD CITY, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), (“Biotricity” or the “Company”), a leading Technology-as-a-Service (Taas) company specializing in cutting-edge diagnostic and chronic disease management solutions for healthcare providers and consumers, is proud to announce the expans

GlobeNewswire last month

BTCY
+2.22%
Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025

Company reports Q3-FY25 revenue grew by 21.7% YOY to $3.6 millionManagement continues to drive revenues and efficienciesCompany achieved positive cash flow on current operating basis, before paying interest, dividends and amortization for the second consecutive quarter, up 114.5% from the prior quarter; management expects to continue to see cash flows improveRecurring technology fees, existing and new customer sales see continued growthReduced SG&A to $2.38 million from $3.0 million, down 20.5%

GlobeNewswire 2 months ago

BTCY
+2.22%
Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%

Company expects to report Q3-FY25 revenue growth of 22% from the corresponding prior year quarter to $3.6 million – an 11% increase sequentially from the immediately preceding quarterManagement continues to drive recurring revenue growth and efficienciesCompany to report positive cash flow for Q3-FY25 on current operating basis, before interest, dividends and amortizationCompany to report improved gross margins and operating results, as the Company nears its goal of achieving profitabilityManage

GlobeNewswire 2 months ago

BTCY
+2.22%
Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring Platform

Biotricity Inc. (OTCQB:BTCY), a provider of remote cardiac monitoring solutions, and B-Secur, a leader in biosensing technology, have joined forces to create one of the most advanced, device-neutral platforms for integrated heart monitoring.

PR Newswire 3 months ago

BTCY
+2.22%
Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand

Biotricity Inc. (OTCQB: BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced that it has completed a series of financings that bolster the Company's financial health, reduce execution risk, and provide it with the necessary resources to achieve profitability.

PR Newswire 3 months ago

BTCY
+2.22%
Biotricity Achieves Positive Free Cash Flow Milestone

Biotricity Inc. (OTCQB: BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced achieving positive free cash flow, a measure of financial health and another major milestone towards profitability.

PR Newswire 4 months ago

BTCY
+2.22%
Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025

Company achieved positive cash flow in September on a current operating basis, before paying interest, dividends and amortization; management expects to continue to see cash flows improveCompany reports Q2-FY25 revenue grew by 13% YOY to $3.3 millionGross margins continued to meet management expectations for improvement at 75.3%, a significant improvement from 69.1% for the same period last yearRecurring Technology Fee revenue comprised 94% of total revenue with a 79% gross profit percentageRecu

GlobeNewswire 5 months ago

BTCY
+2.22%
Biotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15th

Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, announced that it will host its Fourth Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 15

GlobeNewswire 5 months ago

BTCY
+2.22%
SWK Holdings Provides Portfolio Update

Company Announces Q3 Earnings and Conference Call Dates DALLAS, TX / ACCESSWIRE / October 17, 2024 /SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized ...

ACCESS Newswire 6 months ago

DERM

ELUT

AOTI.L
Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins

The company has achieved EBIDTA positive on a go-forward cash basis REDWOOD CITY, CA / ACCESSWIRE / October 3, 2024 /Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company that is reshaping the landscape of the healthcare ...

ACCESS Newswire 6 months ago

BTCY
+2.22%
Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States

REDWOOD CITY, CA / ACCESSWIRE / September 26, 2024 / Biotricity Inc. (OTCQB:BTCY), a leading Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with cutting-edge remote monitoring and diagnostic solutions, announces ...

ACCESS Newswire 6 months ago

BTCY
+2.22%
Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals

REDWOOD CITY, CA / ACCESSWIRE / September 19, 2024 /Biotricity Inc. (OTCQB:BTCY), a leading Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with cutting edge remote monitoring and diagnostic solutions, announces the ...

ACCESS Newswire 7 months ago

BTCY
+2.22%
Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025

The Company shows continued progress towards cash-flow break even and profitability Recurring Technology Fee (SaaS) revenue - over 94% of total revenue with a 76% gross margin, which rose over 400 basis points and is expected to continue to trend ...

ACCESS Newswire 8 months ago

BTCY
+2.22%
LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / July 26, 2024 / RedChip Companies will air interviews with LOBO EV Technologies Ltd. (Nasdaq:LOBO) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this ...

ACCESS Newswire 8 months ago

LOBO

BTCY
+2.22%
Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud

REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, ...

ACCESS Newswire 9 months ago

BTCY
+2.22%
Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this ...

ACCESS Newswire 9 months ago

BTCY
+2.22%
ENLV
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

DALLAS, TX / ACCESSWIRE / July 17, 2024 /SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress ...

ACCESS Newswire 9 months ago

BIOL

SWKH

AOTI.L
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, ...

ACCESS Newswire 9 months ago

BIAF

BIAFW

BTCY
+2.22%
Biotricity Announces Accelerated Path to EBITDA Positive

REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its accelerated timeline to achieving EBITDA ...

ACCESS Newswire 9 months ago

BTCY
+2.22%

Performance Overview

Return	BTCY	S&P 500 (^GSPC)
YTD	+58.70%	-6.06%
1-Year	-64.62%	+9.44%
3-Year	-95.12%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Biotricity, Inc. (BTCY)

Biotricity Recognized by Financial Times as One of 2025’s Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed

Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease Management

Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025

Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%

Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring Platform

Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand

Biotricity Achieves Positive Free Cash Flow Milestone

Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025

Biotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15th

SWK Holdings Provides Portfolio Update

Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins

Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States

Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals

Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025

LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud

Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Biotricity Announces Accelerated Path to EBITDA Positive

Performance Overview